Highlights QuidelOrtho Corporation

Equities

QDEL

US2197981051

Real-time Estimate Cboe BZX Other stock markets 17:01:30 13/09/2024 BST			5-day change	1st Jan Change
45.59 ^USD	+1.76%		+4.05%	-38.66%

12:12pm	RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating	MT
09-11	QuidelOrtho Corporation Appoints Lee Bowman as Chief Human Resources Officer	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating	11:12am	MT
QuidelOrtho Shares Rise After Craig-Hallum Upgrade	09-05	MT
Craig-Hallum Upgrades QuidelOrtho to Buy From Hold, Adjusts Price Target to $57 From $40	09-05	MT
Tranche Update on QuidelOrtho Corporation's Equity Buyback Plan announced on August 17, 2022.	08-01	CI
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q2 Revenue $637M, vs. Street Est of $614.9M	07-31	MT
QuidelOrtho Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	07-31	CI
Avantor to Replace Quidel in S&P MidCap 400; Quidel to Replace Hibbett in S&P SmallCap 600	07-24	MT
QuidelOrtho Seeks Inorganic Options	06-05	CI
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ	05-15	CI
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	05-14	RE
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	05-14	MT
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	05-14	RE
Tranche Update on QuidelOrtho Corporation's Equity Buyback Plan announced on August 17, 2022.	05-09	CI
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q1 Revenue $711M, vs. Street Est of $695.1M	05-08	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q1 EPS $0.44, vs. Street Est of $0.40	05-08	MT
QuidelOrtho Corporation Suspends Earnings Guidance for the Year 2024	05-08	CI
QuidelOrtho Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	04-02	MT
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	04-02	MT
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test	04-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights QuidelOrtho Corporation

Equities

QDEL

US2197981051

Highlights

Filters